Physician profile
Allen Kuo
NPI 1598922320
$3,654.61
in general payments reported to CMS, 2019-2025
18 companies · $617 in 2025
The $617 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $1,378 · 2021: $106 · 2022: $552 · 2023: $447 · 2024: $296 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,192.43 | 2020 | |
| Biotronik INC. | $489.82 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $424.87 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $357.05 | 2022-2025 | |
| Boston Scientific Corporation | $330.00 | 2019-2025 | Rotapro, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $266.68 | 2022-2025 | Cardiomems, Aveir |
| Amgen INC. | $197.52 | 2019-2025 | Repatha, Repatha |
| Cvrx, INC. | $81.47 | 2024-2025 | Barostim Neo System |
| Cardiva Medical, INC. | $60.46 | 2024-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $59.38 | 2022-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $41.21 | 2023-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $36.20 | 2023 | Xarelto |
| Abiomed | $32.76 | 2020 | |
| Alnylam Pharmaceuticals INC. | $25.14 | 2022 | |
| Pfizer INC. | $20.99 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $14.21 | 2024 | Zio Monitor, Zio Xt Patch |
| Allergan, INC. | $12.83 | 2020 | |
| Abbvie INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.